In this week’s View, Dr. Eagle looks at the prevalence of overweight and obesity among children, adolescents, and adults in the U.S., with forecasts up to 2050. He then discusses consensus ...
The U.S. Food and Drug Administration (FDA) has approved acoramidis as a treatment to help reduce cardiovascular death and cardiovascular-related hospitalization in patients with transthyretin amyloid ...
The following are key points to remember from a review on national- and state-level prevalence of overweight and obesity among children, adolescents, and adults in the United States (US), 1990–2021, ...
In this interview, Thomas H. Marwick, MD, PhD, FACC, and Alison L. Bailey, MD FACC, discuss the Top Takeaways from 2024 in Cardiovascular (CV) Imaging. Dr. Marwick discusses the SCOT-HEART trial, ...
The following are key points to remember from a 2024 updated international consensus statement on platelet function and genetic testing in percutaneous coronary intervention (PCI): ...
Use of intravascular lithotripsy (IVL) for the treatment of in-stent restenosis (ISR), although off-label, may be safe and feasible, according to a study reviewing data from the ACC's CathPCI Registry ...
Peigh G, Koehler J, Majumder S, et al. The investigators linked the Optum de-identified electronic health record (EHR) data set (2007-2021) with the Medtronic CareLink heart rhythm database. Patients ...
Nonbacterial thrombotic endocarditis (NBTE), previously known as marantic endocarditis, is a rare condition characterized by the formation of sterile vegetations on the surface of heart valves.
Cardiovascular disease (CVD) is the leading cause of pregnancy-related maternal death in the United States, driven by rising rates of hypertension, diabetes mellitus (DM), obesity, smoking, and ...
Submissions for the CV Team and CV Pharmacists Poster Sessions at ACC.25, taking place March 29-31, 2025, in Chicago, IL, are now open. All members of the cardiovascular team are invited to submit ...
Outpatient initiation of sotalol with use of a personal remote ECG device and pharmacist-led dose adjustments is safe and feasible in carefully selected patients. Compared to inpatient loading ...
Individuals with type 2 diabetes (T2D) experienced two-fold more cardiovascular disease events than matched comparisons in the general population as much as 30 years before their diagnosis of T2D, ...